Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2006; 12(12): 1924-1932
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1924
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1924
Figure 3 Five- year survival according to PECAM-1 (A) and HLA-DR antigen (B) expression (HLA-DR positive patients had expression of HLA-DR antigen in more than 15% of their tumor cells).
- Citation: Darom A, Gomatos IP, Leandros E, Chatzigianni E, Panousopoulos D, Konstadoulakis MM, Androulakis G. Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin’s gastric lymphoma patients. World J Gastroenterol 2006; 12(12): 1924-1932
- URL: https://www.wjgnet.com/1007-9327/full/v12/i12/1924.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i12.1924